Aurora Cannabis (ACB) Asset Writedowns and Impairment (2019 - 2025)

Aurora Cannabis (ACB) has 7 years of Asset Writedowns and Impairment data on file, last reported at -$381483.4 in Q3 2025.

• Asset Writedowns and Impairment for Q3 2025 came in at -$381483.4, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$787369.8 (up 65.87% YoY), and the FY2023 annual result was -$16.5 million, changed N/A from the prior year.
• Asset Writedowns and Impairment rose to -$381483.4 in Q3 2025 per ACB's latest filing, from -$405886.5 in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $950.4 million in Q1 2022 and troughed at -$60.4 million in Q3 2022.
• A 5-year average of $82.9 million and a median of -$94317.1 in 2024 frame the typical range for Asset Writedowns and Impairment.
• On a YoY basis, Asset Writedowns and Impairment climbed as much as 26548.31% in 2022 and fell as far as 1155.44% in 2022.
• A 5-year view of Asset Writedowns and Impairment shows it stood at $35.8 million in 2021, then sank by 95.97% to $1.4 million in 2022, then tumbled by 225.08% to -$1.8 million in 2023, then jumped by 77.54% to -$405886.5 in 2024, then gained by 6.01% to -$381483.4 in 2025.
• Business Quant data shows ACB's Asset Writedowns and Impairment at -$381483.4 in Q3 2025, -$405886.5 in Q4 2024, and -$94317.1 in Q2 2024.